Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

The clawback reduction may help to quell souring pharma sentiments, which stem from the UK’s low spending on innovative medicines.

The worlds of technology and entrepreneurship are captivated by recent advances in generative AI and large language models (LLMs). But if the future has arrived, as science fiction writer William ...

OTR will obtain an upfront payment of $20m, which could increase to $30m if certain predefined conditions are met.

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will ...

In today’s digitally transformed world, technology plays a critical role in how pharmaceutical companies do business. From drug discovery to manufacturing and commercialization, technology is powering ...

The EU pharmaceutical reform aims to improve drug accessibility, affordability, and innovation, addressing market protection and antimicrobial resistance. Co-legislators in Europe have reached a ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

InnoCan Pharma ( ($TSE:INNO) ) has provided an announcement. Innocan Pharma has announced the public filing of an amended ...